Iovance Biotherapeutics, Inc. (IOVA) Financials

IOVA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 915.5 million 179.5 million
March 31, 2026 925.7 million 203.9 million
Dec. 31, 2025 913.2 million 214.6 million
Sept. 30, 2025 904.9 million 202.7 million

IOVA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -66.3 million 11.7 million
March 31, 2026 -78.7 million 11.3 million
Dec. 31, 2025 -61.9 million 11.8 million
Sept. 30, 2025 -89.5 million 11.9 million

IOVA Net Income

No data available :(

IOVA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 297.7 million - 46.0 million
March 31, 2026 313.4 million 43.9 million 2.9 million
Dec. 31, 2025 297.0 million - 44.4 million
Sept. 30, 2025 300.8 million - 51.5 million

IOVA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 450.2 million
March 31, 2026 418.5 million
Dec. 31, 2025 407.0 million
Sept. 30, 2025 364.0 million

IOVA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5.4 million 63.9 million 39.3 million -
March 31, 2026 6.6 million 62.5 million 38.9 million -
Dec. 31, 2025 9.3 million 68.9 million 36.1 million -
Sept. 30, 2025 10.8 million 75.2 million 34.6 million -

IOVA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 99.3 million 45.1 million
March 31, 2026 71.4 million 1.0 million
Dec. 31, 2025 86.8 million -100.5 million
Sept. 30, 2025 67.5 million 1.4 million

IOVA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IOVA

Price: $6.98

52 week price:
1.76
6.98

Earnings Per Share: -0.69 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 3.5 million

Ebitda: -22.1 million

Market Capitalization: 3.1 billion

Links: